What is the Best Method For Evaluating Gleason Score and Tumor Extent for MRI/US Fusion Targeted Biopsy?

被引：0
|
作者：
Gordetsky, Jennifer [1 ]
Schultz, Luciana [2 ]
Porter, Kristin [1 ]
Nix, Jeffrey [1 ]
Rais-Bahrami, Soroush [2 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] AC Camargo Canc Ctr, Inst Anat Patol, Santa Barbara Doeste, SP, Brazil
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
959
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [1] What is the Best Method For Evaluating Gleason Score and Tumor Extent for MRI/US Fusion Targeted Biopsy?
    Gordetsky, Jennifer
    Schultz, Luciana
    Porter, Kristin
    Nix, Jeffrey
    Rais-Bahrami, Soroush
    LABORATORY INVESTIGATION, 2018, 98 : 346 - 346
  • [2] Does MRI-TRUS fusion targeted prostate biopsy have better Gleason score concordance between biopsy and prostatectomy?
    Ku, M-H.
    Wei, T-C.
    Lin, T-P.
    Huang, E. Y-H.
    Chung, H-J.
    Kuo, J-Y.
    Huang, W. J.
    Chang, Y-H.
    Wang, H-K.
    Shen, S-H.
    Lin, A. T. L.
    Chen, K-K.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 107 - 108
  • [3] Optimal Method for Reporting Gleason Score and Tumor Volume in MRI-Targeted Prostate Biopsies
    Kong, Qingnuan
    Chintalapati, Suneetha
    Cai, Qi
    Zhou, Ming
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 914 - 915
  • [4] Optimal Method for Reporting Gleason Score and Tumor Volume in MRI-Targeted Prostate Biopsies
    Kong, Qingnuan
    Chintalapati, Suneetha
    Cai, Qi
    Zhou, Ming
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 914 - 915
  • [5] Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
    Wenzel, Mike
    Preisser, Felix
    Wittler, Clarissa
    Hoeh, Benedikt
    Wild, Peter J.
    Tschaebunin, Alexandra
    Bodelle, Boris
    Wuernschimmel, Christoph
    Tilki, Derya
    Graefen, Markus
    Becker, Andreas
    Karakiewicz, Pierre, I
    Chun, Felix K. H.
    Kluth, Luis A.
    Koellermann, Jens
    Mandel, Philipp
    DIAGNOSTICS, 2021, 11 (05)
  • [6] A PRE-BIOPSY NOMOGRAM FOR PREDICTION OF THE RISK OF GLEASON SCORE=7 PROSTATE CANCER ON COMBINED MRI-US FUSION TARGETED AND SYSTEMATIC PROSTATE BIOPSY AMONG MEN WITH NO PREVIOUS BIOPSY
    Bjurlin, Marc
    Wysock, James
    Sakar, Saradwata
    Venkataraman, Rajesh
    Mendhiratta, Neil
    Meng, Xiaosong
    Rosenkrantz, Andrew
    Huang, William
    Lepor, Herbert
    Taneja, Samir
    JOURNAL OF UROLOGY, 2016, 195 (04): : E701 - E701
  • [7] FUSION TARGETED BIOPSY MAY IMPROVE THE AGREEMENT BETWEEN BIOPTICAL AND PATHOLOGICAL GLEASON SCORE
    Porpiglia, Francesco
    Passera, Roberto
    Mele, Fabrizio
    Manfredi, Matteo
    Bertolo, Riccardo
    Garrou, Diletta
    Checcucci, Enrico
    Amparore, Daniele
    Cattaneo, Giovanni
    Bollito, Enrico
    Cirillo, Stefano
    De Pascale, Agostino
    Russo, Filippo
    De Luca, Stefano
    ANTICANCER RESEARCH, 2017, 37 (04) : 2098 - 2099
  • [8] MRI-US fusion targeted biopsy: Optimising the combination of biopsy cores
    Eldred-Evans, D.
    Marra, G.
    Samad, S.
    Puglisi, M.
    Lam, W.
    Polson, A.
    Rottenberg, G.
    Challacombe, B.
    Popert, R.
    BJU INTERNATIONAL, 2015, 115 : 63 - 63
  • [9] Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysis
    Apfelbeck, M.
    Tritschler, S.
    Clevert, D. -A.
    Buchner, A.
    Chaloupka, M.
    Kretschmer, A.
    Herlemann, A.
    Stief, C.
    Schlenker, B.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (01) : 27 - 32
  • [10] USE OF MRI/US FUSION FOR TARGETED PROSTATE BIOPSY IN ACTIVE SURVEILLANCE
    Le, Jesse
    Filson, Christopher
    Margolis, Daniel
    Marks, Leonard
    JOURNAL OF UROLOGY, 2014, 191 (04): : E679 - E679
12345